Nurown

[Dagmar]

Here’s the latest update on Nurown:

https://alsnewstoday.com/news-posts/2020/10/12/brainstorm-details-phase-3-nurown-trial-design-for-treating-rapidly-progressing-als/

[Ann Thomson]

Is it too late to apply for the 3rd trial?  How do you go about signing up ?

[Ruth Salvanou]

Could you kindly give any indication as to when this 3rd trial of NurOwn will be completed and hopefully available on the market .

[Jean-Pierre Le Rouzic]

The results of the phase III of Nurown are out and they are similar to the phase II.

[Duane]

BrainStorm Cell Therapeutics stock dropped significantly today, due to some disappointing results of a phase 3 clinical trial for its leading candidate treatment (NUROWN). The President of Brainstorm said : “We are committed to advancing discussions with the FDA to identify regulatory pathways that may support NurOwn in ALS.”
It’s stock crashed today. Down 67%. Reason: release of negative top-line results from a phase 3 clinical trial for its leading candidate treatment. NurOwn failed to achieve statistically significant efficacy results.

Just know they have been working on this for 10+ years!

[Duane]

BrainStorm Cell Therapeutics stock dropped significantly today, due to some disappointing results of a phase 3 clinical trial for its leading candidate treatment (NUROWN). The President of Brainstorm said : “We are committed to advancing discussions with the FDA to identify regulatory pathways that may support NurOwn in ALS.”
It’s stock crashed today. Down 67%. Reason: release of negative top-line results from a phase 3 clinical trial for its leading candidate treatment. NurOwn failed to achieve statistically significant efficacy results.

Read this short article and see what you think about the whole affair. Just know they have been working on this for 10+ years!

https://www.nasdaq.com/articles/why-brainstorm-cell-therapeutics-stock-imploded-today-2020-11-17